|
End-of-day quote
Korea S.E.
2025-08-05
|
5-day change | 1st Jan Change | ||
| 2,170.00 KRW | +11.91% |
|
-.--% | - |
| Market Cap | 81.09B 58.51M 50.12M 46.9M 42.93M 80.57M 5.6B 81.63M 554M 216M 2.81B 220M 215M 9.3B | P/E 2024 |
64.8x | P/E 2025 | -2.42x |
|---|---|---|---|---|---|
| Enterprise Value | 97.74B 70.52M 60.41M 56.52M 51.74M 97.1M 6.75B 98.39M 668M 260M 3.39B 265M 259M 11.21B | EV / Sales 2024 |
1.24x | EV / Sales 2025 | 1.17x |
| Free-Float |
84.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +11.91% |
| 3 years | 1,399 |  | 3,490 |
| 5 years | 1,399 | | 20,520.83 |
| 10 years | 1,399 | | 28,645.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Young-Seok Lee
CEO | Chief Executive Officer | 62 | 2022-03-30 |
Choi Young
CEO | Chief Executive Officer | 66 | - |
Seong-Su Kim
PRN | Corporate Officer/Principal | 52 | 2022-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Choi Young
CHM | Chairman | 66 | - |
Jong-Jeon Park
BRD | Director/Board Member | 77 | 2022-03-30 |
Seong-Su Kim
BRD | Director/Board Member | 52 | 2022-03-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/20/24 | Buy | Chief Executive Officer | 3,637 | 0.0097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.91% | -.--% | -.--% | -14.90% | 58.51M | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | |
| Average | +2.35% | +5.35% | +28.18% | +46.39% | 379.99B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.31% | +72.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 69.21B 49.94M 42.78M 40.02M 36.64M 68.76M 4.78B 69.67M 473M 184M 2.4B 188M 183M 7.94B | 83.38B 60.17M 51.54M 48.22M 44.14M 82.84M 5.76B 83.94M 570M 222M 2.89B 226M 221M 9.57B |
| Net income | 1.2B 864K 740K 693K 634K 1.19M 82.68M 1.21M 8.18M 3.19M 41.53M 3.24M 3.17M 137M | -33.6B -24.24M -20.77M -19.43M -17.79M -33.38M -2.32B -33.82M -230M -89.53M -1.17B -91.04M -89.05M -3.85B |
| Net Debt | 18B 12.99M 11.13M 10.41M 9.53M 17.89M 1.24B 18.12M 123M 47.97M 624M 48.78M 47.72M 2.07B | 16.64B 12.01M 10.29M 9.63M 8.81M 16.54M 1.15B 16.76M 114M 44.35M 577M 45.1M 44.12M 1.91B |
Employees
232
Sector
Pharmaceuticals
- Stock Market
- Stocks
- A175250 Stock
Select your edition
All financial news and data tailored to specific country editions
